caveat: cross trial comparison but still helpful as we look across trials
#CLL #leusm @MDAndersonNews @ASH_hematology
TFR (Treatment free remission) is a well established concept in CP CML.
But can you do TFR in Ph+ ALL in CR1 among pts who don’t undergo allo-SCT?
👉14 pt retrospective series at #ASH24
Please see us at the poster on Saturday in San Diego.
Work led by Drs Kugler and Khaire